The missing piece in Omicron’s family tree: Where did the variant originate?
There are currently 3 thoeries being considereed by the medical fraternity
Global COVID-19 cases set to triple with over 3 billion omicron infections in coming 2-3 months: IHME
Australia and New Zealand may experience their worst outbreaks of this pandemic
Omicron now in 63 countries; can become dominant in Europe soon: WHO
Overall risk related to Omicron remains very high due to multiple reasons, flags WHO
As told to Parliament (December 10, 2021): 237 Zika virus cases in India so far
All that was discussed in the House through the day
Treatment for COVID-19 in Omicron wave: What to go for, what to avoid
Experimental therapies used to treat COVID-19 in India’s first two waves should not be used this time, warn doctors
Lateral Thoughts: The uncomfortable science of booster vaccine
The disjoint between research and policy has never been so evident than in the case of vaccine boosters
Omicron in southern Africa: ‘Afrophobia’, say Malawians in wake of West’s travel ban
Malawian government says it has the capacity to do genomic sequencing and had not detected the Omicron variant till now
WHO begins monitoring two new variants of COVID-19 named BA.4 and BA.5
The move comes in the footsteps of the global health body declaring two more variants in circulation named XE and XD
Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA
Unclear which combination of updated vaccine will work best; body expected to decide by July
Quarter of the world has antibodies against COVID-19, study reveals
The figure dropped slightly to 21% when vaccinated population were excluded
COVID-19: Is SARS-CoV-2 evolving differently after omicron
Cases are expected to rise with the advent of winter
With omicron reinfections, are we back to square one of the pandemic?
Case surge may not be as bad as during India's 2nd wave but lot depends on govt interventions, citizen behaviour, say experts
COVID-19 is already endemic, lack of data plagues understanding about vaccine efficacy: Gagandeep Kang
Gagandeep Kang, ex-officio member of a working group on COVID-19 vaccines at the WHO, talks to DTE on vaccines, their effectiveness and urgent …
COVID-19: Global risk related to Omicron ‘very high’, warns WHO
WHO urges ramping up surveillance, sequencing and community testing to check SARS-CoV-2’s mutations and omicron’s prevalence
COVID-19: 2 years into pandemic, original virus nowhere as variants take over
Data from GISAID has revealed the current dominance of the GK clade, to which the Delta variant belongs, in nearly every continent
COVID-19: BA.5 spread has differed from one country to another; here is why
Eric Topol, a US-based professor of molecular medicine, argues it is the immunity wall of a country that plays a decisive role in whether BA.…
COVID-19 cases, deaths on the decline in all regions except Western Pacific, Africa
Western Pacific Region and Africa recorded 21% and 20% increase in the number of new weekly deaths respectively
‘COVID-19 wave not distinct entity, will come periodically’
Epidemiologist Dr Chandrakant Lahariya on the new variant, vaccine immunity and India’s preparedness
Haphazard COVID-19 vaccine donations useless for Africa, WHO flags
Countries should be informed 4 weeks in advance, shots should have at least 10-month shelf-life
COVID-19: INSACOG shares genome sequencing data after a gap of 3 months
India sequenced 89,860 samples between January and April, according to the latest bulletin. The total is now 240,570 sequenced samples
Protection against COVID-19 infection, severe disease falls quickly after AstraZeneca 2nd dose: Lancet
Begins to wane after 18-19 weeks; study stresses on need for booster dose
Patients unaware of omicron infection, may be contributing to COVID-19 spread: Report
Study finds 56% people were unaware of infection status
COVID-19: Omicron's stealthy behaviour behind reinfections in people with immunity, says new study
People infected with initial strains had less sustained antibody response to omicron, scientists find
COVID-19: Pfizer, AstraZeneca efficacy significantly reduced against omicron, says UK health agency
Omicron is displaying growth advantage over delta and is poised to become dominant variant in UK
The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US — here’s what it could mean for the UK
While XBB’s mutations enable it to evade our immune systems better than previous omicron subvariants, it doesn’t appear to be causing&…